The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review

Although denosumab (Prolia) has been shown to be a safe and efficacious therapy for osteoporotic patients in numerous clinical trials, few studies have determined its effectiveness in real world clinical practice. A retrospective review of patients prescribed Prolia assessing the impact that noncomp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong-Pack, Matthew, Kalani, Aashish, Hordyk, Jacob, Ioannidis, George, Bensen, Robert, Bensen, William G., Papaioannou, Alexandra, Adachi, Jonathan D., Lau, Arthur N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736226/
https://www.ncbi.nlm.nih.gov/pubmed/26881176
http://dx.doi.org/10.1155/2016/7903128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736226/
https://www.ncbi.nlm.nih.gov/pubmed/26881176
http://dx.doi.org/10.1155/2016/7903128

Ejemplares similares